FDA advisers recommend discontinuing 2 painkillers

02/1/2009 | CNNMoney

An FDA panel voted 14-12 in favor of withdrawing pain drugs Darvon and Darvocet from the U.S. market, citing efficacy concerns and safety risks. An official with Xanodyne Pharmaceuticals, which makes versions of both medicines, said the firm intends to meet with the FDA to discuss the decision "and come up with a plan on how to move forward."

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN